PDT Partners’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-8,128
| Closed | -$291K | – | 928 |
|
|
2021
Q4 | $291K | Sell |
8,128
-8,381
| -51% | -$300K | 0.02% | 675 |
|
|
2021
Q3 | $703K | Buy |
16,509
+128
| +0.8% | +$5.45K | 0.05% | 409 |
|
|
2021
Q2 | $709K | Sell |
16,381
-783
| -5% | -$33.9K | 0.05% | 441 |
|
|
2021
Q1 | $700K | Buy |
+17,164
| New | +$700K | 0.05% | 439 |
|
|
2018
Q2 | – | Sell |
-6,252
| Closed | -$311K | – | 508 |
|
|
2018
Q1 | $311K | Sell |
6,252
-5,548
| -47% | -$276K | 0.01% | 491 |
|
|
2017
Q4 | $636K | Sell |
11,800
-1,800
| -13% | -$97K | 0.02% | 400 |
|
|
2017
Q3 | $789K | Hold |
13,600
| – | – | 0.03% | 383 |
|
|
2017
Q2 | $671K | Sell |
13,600
-3,507
| -21% | -$173K | 0.03% | 374 |
|
|
2017
Q1 | $743K | Sell |
17,107
-5,293
| -24% | -$230K | 0.04% | 347 |
|
|
2016
Q4 | $1.1M | Sell |
22,400
-200
| -0.9% | -$9.8K | 0.07% | 325 |
|
|
2016
Q3 | $1.08M | Hold |
22,600
| – | – | 0.06% | 296 |
|
|
2016
Q2 | $1.21M | Buy |
+22,600
| New | +$1.21M | 0.1% | 246 |
|
|
2014
Q2 | – | Sell |
-23,557
| Closed | -$968K | – | 1394 |
|
|
2014
Q1 | $968K | Buy |
23,557
+9,056
| +62% | +$372K | 0.02% | 686 |
|
|
2013
Q4 | $553K | Sell |
14,501
-48,417
| -77% | -$1.85M | 0.07% | 379 |
|
|
2013
Q3 | $1.51M | Buy |
+62,918
| New | +$1.51M | 0.04% | 616 |
|